Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
16 results
- D3.519 - Post-COVID-19 Reshaping of Molecular IgE Sensitization Profiles to Seasonal and Indoor Allergens
- D3.520 - Post-COVID Olfactory and Taste Dysfunction in Students at a South African Medical School
D3.521 - Dermatologic adverse effects of COVID-19 vaccination
- D3.522 - Post-Vaccination SARS-CoV-2 Infections: Evidence, Severity, and Outcomes
D3.523 - Early childhood: a risk predictor for post-COVID-19 pulmonary sequelae in children
- D3.524 - Clinical use of procalcitonin and IL-6 in diagnosis of bacterial superinfection in COVID-19
- D3.525 - One- year hospital readmission after pediatric COVID- 19 hospitalization: a single- center cohort study
- D3.526 - Baseline demographic characteristics and early-life exposures in infants born during and after the COVID-19 pandemic: A comparison of the CORAL and FLORAL birth cohorts
- D3.527 - Multisystem Inflammatory Syndrome in Children (MIS-C) as a Condition Resulting from Immune Dysregulation: What has Coronavirus Infection Taught Us? (Case Study)
D3.529 - Altered Virulence of Pseudomonas aeruginosa from Polystyrene-Fed Zophobas atratus Larvae and Immunological Effects of Microplastics on Murine Lungs
- D3.530 - Nonresponsiveness to Hepatitis B Vaccine Is Characterized by Reduced T Stem Cell Memory (TSCM) Cells
- D3.531 - Diverse Infectious Disease Outcomes After SARS CoV 2 Infection in Children and Adolescents: A Nationwide Matched Cohort Study
- D3.536 - Staphylococcus aureus bacteria as a causative agent of upper respiratory tract allergies
- D3.532 - Influence of sensitization on persistent symptoms of chronic fatigue
D3.533 - Prevalence of dysplasia and cervical cancer of papillomavirus origin in women of different age groups
- D3.537 - Immunologic and other factors influencing clearance of viral hepatitis infections
Download the app
The congress at your fingertips
Available on
Download